Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

AddLife AB (0REZ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
105.80 -13.70    -11.46%
08:33:49 - Real-time Data. Currency in SEK ( Disclaimer )
  • Volume: 12
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 105.80 - 105.80
Type:  Equity
Market:  United Kingdom
ISIN:  SE0014401378 
SEDOL:  BMC5705
AddLife 105.80 -13.70 -11.46%

ST:0REZ Financials

 
This summary provides an overview of the most significant critical numbers from each of the AddLife AB financial reports, including theAddLife AB income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the ST:ALIFb financials over time via breakdowns of their annual reports.

AddLife AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 2,570 million compared to SEK 2,457 million a year ago. Net income was SEK 62 million compared to SEK 174 million a year ago. Basic earnings per share from continuing operations was SEK 0.52 compared to SEK 1.43 a year ago. Diluted earnings per share from continuing operations was SEK 0.52 compared to SEK 1.42 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

0REZ Income Statement & Profits

Gross margin TTM 37.17%
Operating margin TTM 5.88%
Net Profit margin TTM 1.96%
Return on Investment TTM 4.05%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 2544 2319 2365 2457
Gross Profit 919 859 895 926
Operating Income -88 132 136 175
Net Income -41 25 33 174

0REZ Balance Sheet

Quick Ratio MRQ 0.41
Current Ratio MRQ 0.84
LT Debt to Equity MRQ 51.21%
Total Debt to Equity MRQ 106.68%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 12745 13319 13828 13243
Total Liabilities 7785 8131 8537 8071
Total Equity 4960 5188 5291 5172

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 6.34
Revenue/Share TTM 79.48
Operating Cash Flow  10.41%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 448 138 82 105
Cash From Investing Activities -93 -77 -66 -81
Cash From Financing Activities -283 -89 -128 -54
Net Change in Cash 43 -38 -79 -30
* In Millions of SEK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALIFb Price Commentary

Write your thoughts about AddLife AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email